Showing results (1-10 of 149) with videos related to
Sort By:
Pageof 15
Cancer Journal (Sudbury, Mass.)|March 25, 2024
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic DiseaseJames W Smithy, Paul B ChapmanJournal of Surgical Oncology|April 8, 2021
Pancreas cancer: Therapeutic trials in metastatic diseaseJames W Smithy, Eileen M O'ReillyCancer Cell|November 1, 2024
Intratumoral vidutolimod in combination with PD-1 blockade in locoregionally advanced melanomaJames W Smithy, Michael A PostowClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2023
CD16+ Macrophages: An Emerging Biomarker for Combined CTLA-4 and PD-1 BlockadeJames W Smithy, Jason J LukeCancer Discovery|March 8, 2022
Adjuvant PD-1 Blockade in Resected Melanoma: Is Preventing Recurrence Enough?James W Smithy, Alexander N ShoushtariTransplantation and Cellular Therapy|March 15, 2025
The Clinical TIL Experience in Melanoma: Past, Present, FutureJames W Smithy, Adam J Schoenfeld, Allison Betof WarnerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2021
Facts and Hopes in Prediction, Diagnosis, and Treatment of Immune-Related Adverse EventsJames W Smithy, David M Faleck, Michael A PostowJournal of Immunotherapy (Hagerstown, Md. : 1997)|December 8, 2020
Checkpoint Blockade in Melanoma Patients With Underlying Chronic Lymphocytic LeukemiaJames W Smithy, Matthew J Pianko, Colleen Maher, et al.Journal for Immunotherapy of Cancer|November 28, 2022
Ensuring equity in the era of HLA-restricted cancer therapeuticsJames W Smithy, Amanda Blouin, Lisa C Diamond, et al.Frontiers in Immunology|January 28, 2022
Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in MelanomaKimberly Loo, James W Smithy, Michael A Postow, et al.Pageof 15